COMP <GO>
NVNO vs SNOA // FORWARD P/E MULTIPLE
enVVeno Medical Corporation (NASDAQ) VS. Sonoma Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: NVNO 0
— SNOA 3
■ METRIC PARITY
LAST: $7.02 (+4.08%) • MKT CAP: $4.9M
forward-pe
—
LAST: $1.20 (+5.26%) • MKT CAP: $5.7M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVNO VS. SNOA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVNO | SNOA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 38.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -12.60% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 0.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 36.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | SNOA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.7 | 39.8 | -5.08 | SNOA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.9M | $5.7M | -$868.4K | SNOA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVNO REV | SNOA REV | NVNO GROSS % | SNOA GROSS % | NVNO FCF | SNOA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $19.5M | — | 38.0% | -$15.6M | -$4.1M |
| FY 2024 | $0 | $14.3M | — | 38.2% | -$16.9M | -$168.0K |
| FY 2023 | $0 | $12.7M | — | — | -$18.9M | -$2.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVNO // BETA —
SNOA // BETA —